Product description

Modafinil is an active substance that is used for the treatment of narcolepsy as well as for negative symptoms associated with shift work. Its molecular structure differs significantly from amphetamines and it is administered orally in the form of tablets.

Comprehensive documentation for drug registration of Modafinil can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
68693-11-8 ASMF USP


Modafinil (Narcoleptic/ Antipsychotic)

Country availability

Available worldwide

Lidia Vereckei

Contact person

Lidia Vereckei

General Manager

email   phone